BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22173517)

  • 1. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
    Saidel-Odes L; Polachek H; Peled N; Riesenberg K; Schlaeffer F; Trabelsi Y; Eskira S; Yousef B; Smolykov R; Codish S; Borer A
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):14-9. PubMed ID: 22173517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
    Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
    Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.
    Wiener-Well Y; Rudensky B; Yinnon AM; Kopuit P; Schlesinger Y; Broide E; Lachish T; Raveh D
    J Hosp Infect; 2010 Apr; 74(4):344-9. PubMed ID: 19783067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.
    Ben-David D; Masarwa S; Navon-Venezia S; Mishali H; Fridental I; Rubinovitch B; Smollan G; Carmeli Y; Schwaber MJ;
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):845-53. PubMed ID: 21828964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
    Huttner B; Haustein T; Uçkay I; Renzi G; Stewardson A; Schaerrer D; Agostinho A; Andremont A; Schrenzel J; Pittet D; Harbarth S
    J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective.
    Cohen MJ; Block C; Levin PD; Schwartz C; Gross I; Weiss Y; Moses AE; Benenson S
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):673-8. PubMed ID: 21666398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.
    Borer A; Eskira S; Nativ R; Saidel-Odes L; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Infect Control Hosp Epidemiol; 2011 Dec; 32(12):1158-65. PubMed ID: 22080653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
    Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
    Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
    Zuckerman T; Benyamini N; Sprecher H; Fineman R; Finkelstein R; Rowe JM; Oren I
    Bone Marrow Transplant; 2011 Sep; 46(9):1226-30. PubMed ID: 21057549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.
    Kochar S; Sheard T; Sharma R; Hui A; Tolentino E; Allen G; Landman D; Bratu S; Augenbraun M; Quale J
    Infect Control Hosp Epidemiol; 2009 May; 30(5):447-52. PubMed ID: 19301985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
    Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
    Benenson S; Navon-Venezia S; Carmeli Y; Adler A; Strahilevitz J; Moses AE; Block C
    Int J Infect Dis; 2009 Sep; 13(5):e295-8. PubMed ID: 19329345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
    Mills JP; Talati NJ; Alby K; Han JH
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):55-60. PubMed ID: 26455382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.
    Oren I; Sprecher H; Finkelstein R; Hadad S; Neuberger A; Hussein K; Raz-Pasteur A; Lavi N; Saad E; Henig I; Horowitz N; Avivi I; Benyamini N; Fineman R; Ofran Y; Haddad N; Rowe JM; Zuckerman T
    Am J Infect Control; 2013 Dec; 41(12):1167-72. PubMed ID: 24274912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
    Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
    J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study.
    Quinio B; Albanèse J; Bues-Charbit M; Viviand X; Martin C
    Chest; 1996 Mar; 109(3):765-72. PubMed ID: 8617089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
    Lambelet P; Tascini C; Fortunato S; Stefanelli A; Simonetti F; Vettori C; Leonildi A; Menichetti F
    New Microbiol; 2017 Jul; 40(3):161-164. PubMed ID: 28513809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.